New treatments for dyslipidemia

Clin Investig Arterioscler. 2021 May:33 Suppl 1:1-2. doi: 10.1016/j.arteri.2021.02.003.

[Article in English, Spanish]

Authors

Leopoldo Pérez de Isla¹, Pedro Valdivielso²

Affiliations

¹ Servicio de Cardiología, Hospital Clínico San Carlos, IDISSC, Madrid, España; Facultad de Medicina, Universidad Complutense, Madrid, España.
² Servicio de Medicina Interna, Hospital Virgen de la Victoria, Málaga, España; Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, España. Electronic address: valdivielso@uma.es.

PMID: 33966806
DOI: 10.1016/j.arteri.2021.02.003

No abstract available

Publication types

Editorial

MeSH terms

Dyslipidemias* / complications
Dyslipidemias* / drug therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors